What is the expected growth forecast for the COX-2 ELISA Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the COX-2 ELISA Kit market?

Increasing demand for diagnostic kits and rising awareness of chronic diseases drive the market.

What are the challenges faced by the COX-2 ELISA Kit market?

Stringent regulatory requirements and high development costs are major challenges.

Which regions are the leaders in the COX-2 ELISA Kit market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the COX-2 ELISA Kit market?

Major players include Abbott, Roche, and Siemens, offering a range of diagnostic kits.

What are the future opportunities in the COX-2 ELISA Kit market?

Emerging economies and increasing research activities offer growth opportunities.

How does technology impact the COX-2 ELISA Kit market?

Advances in technology improve kit sensitivity and specificity, driving market growth.

What is the current regulatory landscape for the COX-2 ELISA Kit market?

Regulatory bodies like FDA and CE ensure compliance with strict guidelines and standards.

Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Growth Opportunities & Strategic Forecast 2033

Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit by Application (Hospital, Research Institute, Others), by Types (Human, Mouse, Rat, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Size | CAGR 8.2 Forecast 2033

Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Growth Opportunities & Strategic Forecast 2033

🏭 Healthcare🌍 Global

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 129

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Overview

The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market is a crucial segment of the life sciences industry, playing a vital role in the diagnosis and research of various diseases. As the global healthcare landscape continues to evolve, the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market size is expected to experience significant growth, driven by increasing demand for accurate and reliable diagnostic tools. The growth outlook for the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market forecast is promising, with the global market valued at approximately $235 million in 2025. The market forecast suggests a compound annual growth rate (CAGR) of around 8%, driven by macro drivers such as advancements in technology, rising healthcare expenditure, and an increasing prevalence of chronic diseases.

Loading chart…

Key forces shaping the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit industry include technology shifts towards automation and digitalization, regulatory requirements for accurate and reliable diagnostic tools, and competitive intensity driven by the presence of established players and new entrants. The largest region for the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rising healthcare expenditure and increasing demand for diagnostic tools. The industry expansion is expected to be driven by the growing need for accurate and reliable diagnostic tools, driving the demand for Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kits.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific (China) Co.,Ltd.; Abcam; MyBiosource,Inc.; RayBiotech,Inc.; Bio-Techne; Merck; Enzo Life Sciences,Inc.; Shanghai Korain Biotech Co.,Ltd.; LifeSpan BioSciences,Inc; Elabscience Biotechnology Inc.; CUSABIO; Wuhan Fine Biotech Co.,Ltd.; Biomatik; Biorbyt; Assay Genie; CLOUD-CLONE CORP.; Creative Diagnostics; Abbexa; Geno Technology,Inc.; AFG Scientific; ZodelBiotec Ltd.; Cell Signaling Technology,Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market is experiencing significant growth, driven by various factors. The market dynamics are shaped by several key elements that influence its growth forecast and overall market size.

Growth Drivers2 items

Increasing demand for Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit in research and diagnostic applications, driven by the rising prevalence of inflammatory diseases and cancer

Advancements in technology, such as the development of high-sensitivity COX-2 ELISA Kits, which enable more accurate and reliable results, contributing to the growth of the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market size

Restraints2 items

High costs associated with the development and production of Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kits, which can limit their adoption in resource-constrained settings and impact the growth forecast

Stringent regulatory requirements and quality control measures, which can create barriers to entry for new manufacturers and affect the overall Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America, which offer significant growth potential for the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market due to increasing demand for diagnostic and research tools

Growing focus on personalized medicine and targeted therapies, which is expected to drive the adoption of COX-2 ELISA Kits in clinical settings and contribute to the growth forecast

Challenges2 items

Intense competition among established players in the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market, which can lead to pricing pressures and impact profit margins

Need for continuous innovation and investment in research and development to stay ahead of the competition and address evolving customer needs, which can be a challenge for manufacturers and affect the overall market size

Market Segmentation

Loading chart…

The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market can be segmented based on application, which includes research institutions, pharmaceutical companies, and hospitals. This segmentation contributes to the overall market size by highlighting the demand for COX-2 ELISA kits in various industries. The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit segmentation by application provides valuable insights into the market, allowing companies to tailor their products to specific customer needs.

In terms of types, the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market can be divided into sandwich ELISA, competitive ELISA, and indirect ELISA. These subtypes contribute to the overall market size by offering a range of options for customers to choose from, depending on their specific research requirements. Understanding the market taxonomy of COX-2 ELISA kits is crucial for companies to develop effective marketing strategies and product development plans.

Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Segmentation Breakdown9 items

Application

Hospital

Research Institute

Others

Types

Human

Mouse

Rat

Others

Regional Insights

Loading chart…

The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market growth is expected to vary across regions, driven by distinct factors. North America is the largest region, accounting for approximately 40% of the market share, driven by key drivers such as high adoption rates of ELISA kits in research institutions, favorable policies supporting biomedical research, and substantial investments in the healthcare sector.

The fastest-growing region is Asia Pacific, driven by increasing demand for ELISA kits, expanding infrastructure in the healthcare sector, and growing investments in research and development. Europe is also a significant region, with key drivers including established research ecosystems, mature healthcare infrastructure, and strong regulatory frameworks. Latin America and Middle East & Africa are expected to experience moderate growth, driven by growing demographics and increasing adoption of ELISA kits in research institutions.

The regional forecast indicates that the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market will continue to evolve, with each region presenting unique opportunities and challenges. Understanding these regional dynamics is crucial for stakeholders to develop effective strategies and capitalize on emerging trends in the market.

Competitive Landscape

The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market exhibits a moderately consolidated structure, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit competitive landscape is characterized by key players focusing on certifications, regulatory approvals, and strategic partnerships to differentiate themselves. Global companies tend to dominate the market, but local players are also gaining traction through targeted marketing and localized product offerings.

Companies in this market employ various strategies to stay competitive, including M&A, partnerships, product launches, and R&D investments. They also focus on differentiation through technology, service models, and channel strength. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To mitigate these risks, companies are exploring strategies like premium pricing, OEM tie-ups, and innovation pipelines. The following companies are notable for their strategic focuses:

Thermo Fisher Scientific: regional expansion

Abcam: premium pricing

MyBiosource: innovation pipeline

RayBiotech: local manufacturing

Bio-Techne: OEM tie-ups

Merck: vertical integration

Key Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Companies22 items

Thermo Fisher Scientific (China) Co.,Ltd.

Abcam

MyBiosource,Inc.

RayBiotech,Inc.

Bio-Techne

Merck

Enzo Life Sciences,Inc.

Shanghai Korain Biotech Co.,Ltd.

LifeSpan BioSciences,Inc

Elabscience Biotechnology Inc.

CUSABIO

Wuhan Fine Biotech Co.,Ltd.

Biomatik

Biorbyt

Assay Genie

CLOUD-CLONE CORP.

Creative Diagnostics

Abbexa

Geno Technology,Inc.

AFG Scientific

ZodelBiotec Ltd.

Cell Signaling Technology,Inc.

Market Ecosystem

The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This ecosystem is characterized by the creation and capture of value through the development, manufacturing, and distribution of COX-2 ELISA kits. The value chain analysis of this ecosystem reveals the intricate relationships between various participants, influencing the overall efficiency and effectiveness of the market.

Raw material/component suppliers — providing key reagents and materials

OEMs / manufacturers — producing COX-2 ELISA kits

Technology providers — developing underlying technologies and protocols

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance services

End users / buyers — utilizing COX-2 ELISA kits in research and diagnostics

Regulators/standards bodies — establishing guidelines and standards for kit development and use

The flow of value within the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit ecosystem is influenced by control points, such as regulatory approvals and technology advancements, which can impact adoption rates and market growth. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's efficiency. Furthermore, switching costs, partnerships, and interoperability requirements can vary among participants, leading to differences in ecosystem dynamics across regions.

Recent Industry Insights

The Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have led to the expansion of product portfolios and enhanced research capabilities. Notable mergers and acquisitions have also resulted in the consolidation of market share, driving growth and innovation in the industry.

Additionally, several product and technology launches have improved the sensitivity and specificity of COX-2 ELISA kits, catering to the increasing demand for accurate diagnostic tools. Regulatory changes have also played a crucial role in shaping the industry, with a focus on standardizing manufacturing practices and ensuring compliance with strict quality control measures. As a result, the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit industry trends are expected to continue evolving, driven by advancements in technology and shifting consumer preferences.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market. The market attractiveness is relatively high due to the increasing demand for in vitro diagnostic tests. The competitive intensity is moderate, with a few key players dominating the market. The long-term outlook for the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market outlook is positive, driven by advancements in medical research and diagnostics. The innovation landscape is characterized by ongoing developments in ELISA kit technology, improving sensitivity and specificity.

The demand-supply balance is expected to remain stable, with manufacturers adjusting production to meet growing demand. However, key risk factors include regulatory changes, intense competition, and fluctuations in raw material prices. Overall, the Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit market is poised for growth, driven by its increasing applications in medical research and diagnostics.

11 items

1. Executive Summary

2. Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Research Institute

6.1.3. Others

6.2. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Human

6.2.2. Mouse

6.2.3. Rat

6.2.4. Others

6.3. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Competition by Key Manufacturers

8.1. Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific (China) Co.,Ltd.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Abcam

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. MyBiosource,Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. RayBiotech,Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bio-Techne

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Merck

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Enzo Life Sciences,Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Shanghai Korain Biotech Co.,Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. LifeSpan BioSciences,Inc

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Elabscience Biotechnology Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. CUSABIO

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Wuhan Fine Biotech Co.,Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Biomatik

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Biorbyt

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Assay Genie

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. CLOUD-CLONE CORP.

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Creative Diagnostics

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Abbexa

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Geno Technology,Inc.

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. AFG Scientific

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. ZodelBiotec Ltd.

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Cell Signaling Technology,Inc.

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market

Figure 4: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market: Drivers

Figure 5: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market: Challenges

Figure 6: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market: Trends

Figure 7: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market: Opportunity

Figure 8: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market: Restraint

Figure 9: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Value (USD Million) By Region

Figure 15: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Value (USD Million) By Region

Figure 23: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

97 items

Table 1: Market Segmentation Analysis

Table 2: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Value (USD Million) By Region

Table 10: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific (China) Co.,Ltd. Basic Information And Sales Area

Table 31: Thermo Fisher Scientific (China) Co.,Ltd.. Products Portfolio

Table 32: Abcam Basic Information And Sales Area

Table 33: Abcam. Products Portfolio

Table 34: MyBiosource,Inc. Basic Information And Sales Area

Table 35: MyBiosource,Inc.. Products Portfolio

Table 36: RayBiotech,Inc. Basic Information And Sales Area

Table 37: RayBiotech,Inc.. Products Portfolio

Table 38: Bio-Techne Basic Information And Sales Area

Table 39: Bio-Techne. Products Portfolio

Table 40: Merck Basic Information And Sales Area

Table 41: Merck. Products Portfolio

Table 42: Enzo Life Sciences,Inc. Basic Information And Sales Area

Table 43: Enzo Life Sciences,Inc.. Products Portfolio

Table 44: Shanghai Korain Biotech Co.,Ltd. Basic Information And Sales Area

Table 45: Shanghai Korain Biotech Co.,Ltd.. Products Portfolio

Table 46: LifeSpan BioSciences,Inc Basic Information And Sales Area

Table 47: LifeSpan BioSciences,Inc. Products Portfolio

Table 48: Elabscience Biotechnology Inc. Basic Information And Sales Area

Table 49: Elabscience Biotechnology Inc.. Products Portfolio

Table 50: CUSABIO Basic Information And Sales Area

Table 51: CUSABIO. Products Portfolio

Table 52: Wuhan Fine Biotech Co.,Ltd. Basic Information And Sales Area

Table 53: Wuhan Fine Biotech Co.,Ltd.. Products Portfolio

Table 54: Biomatik Basic Information And Sales Area

Table 55: Biomatik. Products Portfolio

Table 56: Biorbyt Basic Information And Sales Area

Table 57: Biorbyt. Products Portfolio

Table 58: Assay Genie Basic Information And Sales Area

Table 59: Assay Genie. Products Portfolio

Table 60: CLOUD-CLONE CORP. Basic Information And Sales Area

Table 61: CLOUD-CLONE CORP.. Products Portfolio

Table 62: Creative Diagnostics Basic Information And Sales Area

Table 63: Creative Diagnostics. Products Portfolio

Table 64: Abbexa Basic Information And Sales Area

Table 65: Abbexa. Products Portfolio

Table 66: Geno Technology,Inc. Basic Information And Sales Area

Table 67: Geno Technology,Inc.. Products Portfolio

Table 68: AFG Scientific Basic Information And Sales Area

Table 69: AFG Scientific. Products Portfolio

Table 70: ZodelBiotec Ltd. Basic Information And Sales Area

Table 71: ZodelBiotec Ltd.. Products Portfolio

Table 72: Cell Signaling Technology,Inc. Basic Information And Sales Area

Table 73: Cell Signaling Technology,Inc.. Products Portfolio

Table 74: Global Market Value (USD Million) (2025-2032) By Application

Table 75: Global Market Share (%) By Application (2032)

Table 76: Global Market Value (USD Million) (2025-2032) By Types

Table 77: Global Market Share (%) By Types (2032)

Table 78: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Value (USD Million) By Region

Table 79: Global Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Share (%) By Region (2025-2032)

Table 80: North America Market Value (USD Million) (2025-2032) By Country

Table 81: North America Market Value (USD Million) (2025-2032) By Application

Table 82: North America Market Value (USD Million) (2025-2032) By Types

Table 83: Europe Market Value (USD Million) (2025-2032) By Country

Table 84: Europe Market Value (USD Million) (2025-2032) By Application

Table 85: Europe Market Value (USD Million) (2025-2032) By Types

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 89: South America Market Value (USD Million) (2025-2032) By Country

Table 90: South America Market Value (USD Million) (2025-2032) By Application

Table 91: South America Market Value (USD Million) (2025-2032) By Types

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 95: Research Programs/Design For This Report

Table 96: Key Data Information From Secondary Sources

Table 97: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Prostaglandin-endoperoxide Synthase 2 (COX-2) ELISA Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific (China) Co.,Ltd.; Abcam; MyBiosource,Inc.; RayBiotech,Inc.; Bio-Techne; Merck; Enzo Life Sciences,Inc.; Shanghai Korain Biotech Co.,Ltd.; LifeSpan BioSciences,Inc; Elabscience Biotechnology Inc.; CUSABIO; Wuhan Fine Biotech Co.,Ltd.; Biomatik; Biorbyt; Assay Genie; CLOUD-CLONE CORP.; Creative Diagnostics; Abbexa; Geno Technology,Inc.; AFG Scientific; ZodelBiotec Ltd.; Cell Signaling Technology,Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options